Close

Analyst Ratings for Rapt Therapeutics (RAPT)

RAPT Rating Summary

RAPT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RAPT
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $23.88 (+197.7%) * Over Last 12-Mos
Rating Score: 7.1 / 10   Percentile Rank: 77%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/21/2024 UBS Eliana Merle Downgrade Neutral
(Buy)
10.00
(61.00)
6.87
(8.02)
16.74% Details
2/21/2024 Leerink Partners Thomas Smith Downgrade Market Perform
(Outperform)
10.00
(N/A)
6.87
(8.02)
16.74% Details